Hypothalamic histamine, growth rate, plasma prolactin and growth hormone levels in rats with long-term portacaval anastomosis

Inflammation Research

Volumn 48, Issue 2, 1999, Pages 81-85

  Lozeva, V ^a,b   Anttila, E ^a   Tuominen, R K ^c   Hippelainen M ^d   Mannisto P T ^a   Tuomisto, L ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b MEDICAL UNIVERSITY OF VARNA   (Bulgaria)

^c UNIVERSITY OF HELSINKI   (Finland)

^d KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Brain histamine; Growth hormone blood; Growth rate; Portacaval anastomosis; Prolactin blood

Indexed keywords

GROWTH HORMONE; HISTAMINE; HISTAMINE DERIVATIVE; PROLACTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; GAS CHROMATOGRAPHY; GROWTH HORMONE BLOOD LEVEL; GROWTH RATE; GROWTH RETARDATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPOTHALAMUS; MALE; MASS SPECTROMETRY; NONHUMAN; PORTOCAVAL SHUNT; PROLACTIN BLOOD LEVEL; RADIOIMMUNOASSAY; RAT; STATISTICAL ANALYSIS;

ANIMALS; GROWTH; HISTAMINE; HISTIDINE; HUMAN GROWTH HORMONE; HYPOTHALAMUS; MALE; METHYLHISTAMINES; PORTACAVAL SHUNT, SURGICAL; PROLACTIN; RATS; RATS, WISTAR;

EID: 0032983456     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050417     Document Type: Article

References (44)

1. Bircher J. The rat with portacaval shunt: An animal model with chronic hepatic failure. Pharmacol Ther 1979;5:219-22.
2. Langer M, Masala A, Alagna S, Rassu S, Madeddu G, Solinas A, et al. Growth hormone (GH) secretion in hepatic encephalopathy. Clin Endocrinol (Oxf) 1981;14:189-92.
3. Masala A, Alagna S, Rovasio PP, Deplano A, Anania V, Chiandussi L, et al. Failure of nomifensine to reduce serum prolactin levels in patients with hepatic encephalopathy. J Endocrinol Invest 1985;8:25-9.
4. Bianchi GP, Marchesini G, Zoli M, Abbiati R, Ferrario E, Fabbri A, et al. Oral BCAA supplementation in cirrhosis with chronic encephalopathy: Effects on prolactin and estradiol levels. Hepatogastroenterology 1992;39:443-6.
5. 3-antagonist and plasma hormone levels. Inflamm Res 1995;44 Suppl 1:S52-3.
6. 3-agonist on plasma prolactin in portocaval shunted and sham operated rats. Inflamm Res 1996;45 Suppl 1:S56-7.
7. Smanik EJ, Mullen KD, Giroski WG, McCullough AJ. The influence of portacaval anastomosis on gonadal and anterior pituitary hormones in a rat model standardized for gender, food intake, and time after surgery. Steroids 1991;56:237-41.
8. Martin JR. Alterations in ingestive behavior following experimental portacaval anastomosis in rats. Physiol Behav 1983;30:749-55.
9. Conjeevaram HS, Mullen KD, May EJ, McCullough AJ. Gender-dependent reduction of spontaneous motor activity and growth in rats subjected to portacaval shunt. Hepatology 1994;19:381-8.
10. Tuomisto J, Mannisto P. Neurotransmitter regulation of anterior pituitary hormones. Pharmacol Rev 1985;37:249-332.
11. Leibowitz SF. Neurochemical-neuroendocrine systems in the brain controlling macronutrient intake and metabolism. Trends Neurosci 1992;15:491-7.
12. Fogel WA, Andrzejewski W, Maslinski C. Brain histamine in rats with hepatic encephalopathy. J Neurochem 1991;56:38-43.
13. Fogel WA, Tuomisto L, Sasiak K, Rokicki W, Rokicki M, MacDonald E, et al. Effect of pargyline on brain N-telemethylhistamine in portocaval-shunted rats: relation to amine neurotransmitters. J Neurochem 1994;62:615-20.
14. Lozeva V, MacDonald E, Belcheva A, Hippelainen M, Kosunen H, Tuomisto L. Long-term effects of portacaval anastomosis on the 5-hydroxytryptamine, histamine and catecholamine neuro-transmitter systems in rat brain. J Neurochem 1998;74:1450-6.
15. 3 receptors in rats with portacaval anastomsosis:in vitro and in vivo studies. Naunyn-Schmiedeberg's Arch Pharmacol 1998:1358:574-81.
16. Cacabelos R. Histaminergic Regulation of the Neuroendocrine System. In: Watanabe T, Wada H, editors. Histaminergic Neurons: Morphology and Function. Boca Raton: CRC Press, 1991:241-71.
17. Knigge U, Warberg J. Neuroendocrine functions of histamine. In: Timmerman H, van der Goot H, editors. New perspectives in histamine research. Basel: Birkhäuser, 1991:29-55.
18. Alvarez EO, Banzan AM. Histamine sensitive sites in hippocampus: Their probable role on prolactin release in male rats. Brain Res Bull 1987;19:165-73.
19. 3-histamine receptors increases the release of prolactin in male rats. Neuroendocrinology 1993;57:654-7.
20. Tuominen RK, Tuomisto L, Mannisto PT. Effect of modified brain histamine contents on prolactin and thyrotropin secretion in male rats. Eur J Endocrinol 1996;134:209-14.
21. Netti C, Sibilia V, Guidobono F, Pecile A. Influence of brain histamine on growth hormone secretion induced by alpha-2-receptor activation. Neuroendocrinology 1993;57:1066-70.
22. Bruno JF, Song J, Xu Y, Berelowitz M. Regulation of hypothalamic preprogrowth hormone-releasing factor messenger ribonucleic acid expression in food-deprived rats: a role for histaminergic neurotransmission. Endocrinology 1993;133:1377-81.
23. Sakata T. Feeding Behaviour. In: Histaminergic Neurons: Morphology and Function. Boca Raton: CRC Press, 1991:297-315.
24. 3 agonists on food and water intake and urine flow in Wistar rats. Brain Res 1998;793:279-88.
25. Lee SH, Fischer B. Porto-caval shunt in the rat. Surgery 1961; 50:668-72.
26. 3H] dopa in various regions of the brain. J Neurochem 1966;13:655-69.
27. Yamatodani A, Fukuda H, Wada H, Iwaeda T, Watanabe T. High-performance liquid chromatographic determination of plasma and brain histamine without previous purification of biological samples: Cation-exchange chromatography coupled with post-column derivatization fluorometry. J Chromatogr 1985;344:115-23.
28. Yamatodani A. Assay of histamine and its metabolites in the brain. In: Watanabe T, Wada H, editors. Histaminergic neurons: morphology and function. Boca Raton: CRC Press, 1991:35-57.
29. Hough LB, Khandelwal JK, Morrishow AM, Green JP. An improved GCMS method to measure tele-methylhistamine. J Pharmacol Methods 1981;5:143-8.
30. Tuomisto L, Ylinen M, Onodera K, Tacke U, Airaksinen M. Comparison of regional brain histamine and tele-methylhistamine levels in genetically epilepsy-prone rats and in rats resistant to epilepsy. Methods Find Exp Clin Pharmacol 1996;18 (Suppl A):155-9.
31. Prell GD, Green JP. Histamine as a neuroregulator. Annu Rev Neurosci 1986;9:209-54.
32. Schwartz JC, Arrang JM, Garbarg M, Pollard H, Ruat M. Histaminergic transmission in the mammalian brain. Physiol Rev 1991;71:1-51.
33. Schwartz JC, Lampart C, Rose C. Properties and regional distribution of histidine decarboxylase in rat brain. J Neurochem 1970;17:1527-44.
34. Schwartz JC, Lampart C, Rose C. Histamine formation in rat brain in vivo: Effects of histidine loads. J Neurochem 1972; 19:801-10.
35. Prell GD, Hough LB, Khandelwal J, Green JP. Lack of a precursor-product relationship between histamine and its metabolites in brain after histidine loading. J Neurochem 1996;67:1938-44.
36. Leibowitz SF. Hypothalamic neurochemical systems mediate drug effects on food intake. Clin Neuropharmacol 1992;15 Suppl 1 Pt A:701A-2.
37. Wada H, Inagaki N, Yamatodani A, Watanabe T. Is the histaminergic neuron system a regulatory center for whole-brain activity? Trends Neurosci 1991;14:415-8.
38. Sakata T. Histamine receptor and its regulation of energy metabolism. Obes Res 1995;3 Suppl 4:541S-8.
39. Sakata T, Yoshimatsu H, Kurokawa M. Hypothalamic neuronal histamine: implications of its homeostatic control of energy metabolism. Nutrition 1997;13:403-11.
40. Mercer LP, Dodds SJ, Weber MD, Dunn JD. Histidine, Histamine, and the neuroregulation of food intake: A review and hypothesis. Nutrition 1990;6:273-7.
41. Lecklin A, Tuomisto L. Fluid balance in rats of three different strains after inhibition of histamine catabolism. Physiol Behav 1995;58:861-7.
42. Lecklin A, Jarvikyla M, Tuomisto L. The effect of metoprine on glucoprivic feeding induced by 2-deoxy-D-glucose. Pharmacol Biochem Behav 1994;49:853-7.
43. Libertun C, McCann SM. The possible role of histamine in the control of prolactin and gonadotropin release. Neuroendocrinology 1976;20:110-20.
44. Knigge U, Matzen S, Warberg J. Histaminergic stimulation of prolactin secretion mediated via H1- or H2-receptors: Dependence on routes of administration. Neuroendocrinology 1986;44:41-8.